Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency.

Authors:
Charlotte K Lautrup Keng W Teik Ai Unzaki Shuji Mizumoto Delfien Syx Heng H Sin Irene K Nielsen Sara Markholt Shuhei Yamada Fransiska Malfait Naomichi Matsumoto Noriko Miyake Tomoki Kosho

Mol Genet Genomic Med 2020 05 4;8(5):e1197. Epub 2020 Mar 4.

Center for Medical Genetics, Shinshu University Hospital, Matsumoto, Japan.

Background: Musculocontractural Ehlers-Danlos Syndrome (mcEDS) is a rare connective tissue disorder caused by biallelic loss-of-function variants in CHST14 (mcEDS-CHST14) or DSE (mcEDS-DSE), both of which result in defective dermatan sulfate biosynthesis. Forty-one patients with mcEDS-CHST14 and three patients with mcEDS-DSE have been described in the literature.

Methods: Clinical, molecular, and glycobiological findings in three additional patients with mcEDS-DSE were investigated.

Results: Three patients from two families shared craniofacial characteristics (hypertelorism, blue sclera, midfacial hypoplasia), skeletal features (pectus and spinal deformities, characteristic finger shapes, progressive talipes deformities), skin features (fine or acrogeria-like palmar creases), and ocular refractive errors. Homozygous pathogenic variants in DSE were found: c.960T>A/p.Tyr320* in patient 1 and c.996dupT/p.Val333Cysfs*4 in patients 2 and 3. No dermatan sulfate was detected in the urine sample from patient 1, suggesting a complete depletion of DS.

Conclusion: McEDS-DSE is a congenital multisystem disorder with progressive symptoms involving craniofacial, skeletal, cutaneous, and cardiovascular systems, similar to the symptoms of mcEDS-CHST14. However, the burden of symptoms seems lower in patients with mcEDS-DSE.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.1197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216804PMC
May 2020

Publication Analysis

Top Keywords

dermatan sulfate
12
patients mceds-dse
12
ehlers-danlos syndrome
8
three patients
8
musculocontractural ehlers-danlos
8
patients
6
mceds-dse
5
progressive talipes
4
talipes deformities
4
shapes progressive
4
finger shapes
4
characteristic finger
4
deformities skin
4
features fine
4
creases ocular
4
ocular refractive
4
palmar creases
4
acrogeria-like palmar
4
deformities characteristic
4
fine acrogeria-like
4

Similar Publications

An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19.

Authors:
Julia Y Wang Wei Zhang Michael W Roehrl Victor B Roehrl Michael H Roehrl

bioRxiv 2021 Feb 22. Epub 2021 Feb 22.

We aim to establish a comprehensive COVID-19 autoantigen atlas in order to understand autoimmune diseases caused by SARS-CoV-2 infection. Based on the unique affinity between dermatan sulfate and autoantigens, we identified 348 proteins from human lung A549 cells, of which 198 are known targets of autoantibodies. Comparison with current COVID data identified 291 proteins that are altered at protein or transcript level in SARS-CoV-2 infection, with 191 being known autoantigens. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Soluble syndecan-1 and glycosaminoglycans in preeclamptic and normotensive pregnancies.

Authors:
H Hassani Lahsinoui F Amraoui L J A Spijkers G J M Veenboer S L M Peters N van Vlies L Vogt C Ris-Stalpers B J H van den Born G B Afink

Sci Rep 2021 Feb 23;11(1):4387. Epub 2021 Feb 23.

Reproductive Biology Laboratory, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Preeclampsia, an important cause of maternal and fetal morbidity and mortality, is associated with increased sFLT1 levels and with structural and functional damage to the glycocalyx contributing to endothelial dysfunction. We investigated glycocalyx components in relation to preeclampsia in human samples. While soluble syndecan-1 and heparan sulphate were similar in plasma of preeclamptic and normotensive pregnant women, dermatan sulphate was increased and keratan sulphate decreased in preeclamptic women. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.

Authors:
Christiane S Hampe Jacob Wesley Troy C Lund Paul J Orchard Lynda E Polgreen Julie B Eisengart Linda K McLoon Sebahattin Cureoglu Patricia Schachern R Scott McIvor

Biomolecules 2021 Jan 29;11(2). Epub 2021 Jan 29.

Immusoft Corp, Minneapolis, MN 55413, USA.

Mucopolysaccharidosis type I (MPS I) is a lysosomal disease, caused by a deficiency of the enzyme alpha-L-iduronidase (IDUA). IDUA catalyzes the degradation of the glycosaminoglycans dermatan and heparan sulfate (DS and HS, respectively). Lack of the enzyme leads to pathologic accumulation of undegraded HS and DS with subsequent disease manifestations in multiple organs. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I.

Authors:
Dawn S Peck Jean M Lacey Amy L White Gisele Pino April L Studinski Rachel Fisher Ayesha Ahmad Linda Spencer Sarah Viall Natalie Shallow Amy Siemon J Austin Hamm Brianna K Murray Kelly L Jones Dimitar Gavrilov Devin Oglesbee Kimiyo Raymond Dietrich Matern Piero Rinaldo Silvia Tortorelli

Int J Neonatal Screen 2020 Feb 7;6(1). Epub 2020 Feb 7.

Biochemical Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Enzyme-based newborn screening for Mucopolysaccharidosis type I (MPS I) has a high false-positive rate due to the prevalence of pseudodeficiency alleles, often resulting in unnecessary and costly follow up. The glycosaminoglycans (GAGs), dermatan sulfate (DS) and heparan sulfate (HS) are both substrates for α-l-iduronidase (IDUA). These GAGs are elevated in patients with MPS I and have been shown to be promising biomarkers for both primary and second-tier testing. Read More

View Article and Full-Text PDF
February 2020
Similar Publications

Development of collagen-poly(caprolactone)-based core-shell scaffolds supplemented with proteoglycans and glycosaminoglycans for ligament repair.

Authors:
Pedro J Gouveia Tom Hodgkinson Isabel Amado Joanna M Sadowska Alan J Ryan Sara Romanazzo Simon Carroll Sally-Ann Cryan Daniel J Kelly Fergal J O'Brien

Mater Sci Eng C Mater Biol Appl 2021 Jan 20;120:111657. Epub 2020 Oct 20.

Tissue Engineering Research Group, Department of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Ireland; Trinity Centre for Biomedical Engineering, Trinity College Dublin (TCD), Ireland; Advanced Materials and BioEngineering Research (AMBER) Centre, RCSI, Ireland. Electronic address:

Core-shell scaffolds offer a promising regenerative solution to debilitating injuries to anterior cruciate ligament (ACL) thanks to a unique biphasic structure. Nevertheless, current core-shell designs are impaired by an imbalance between permeability, biochemical and mechanical cues. This study aimed to address this issue by creating a porous core-shell construct which favors cell infiltration and matrix production, while providing mechanical stability at the site of injury. Read More

View Article and Full-Text PDF
January 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap